Answers are grounded in this paper and cite their sources.
Investigates the efficacy of 17beta-HSD10 inhibitors in Alzheimer’s disease, suggesting new therapeutic avenues.
The advent of the first disease-modifying therapies for Alzheimer’s disease (AD) has renewed optimism for effective prevention and treatment strategies. Growing mechanistic insights indicate that AD pathogenesis is multifactorial and...
No takes yet. Share an insight, caveat, or question.
Kwa et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: